Dr Paul T. Menzel joins Ethics Talk to discuss his article: "How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom?"
Beatrice L. Brown joins Ethics Talk to discuss her article, coauthored with Dr Aaron S Kesselheim: "How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices?"
Expedited partner therapy is an ethical and effective treatment for sexually transmitted infection, provided patients are reliable messengers to partners.
AMA J Ethics. 2016;18(3):215-228. doi:
10.1001/journalofethics.2016.18.3.ecas3-1603.
Barry DeCoster, PhD and Lisa Campo-Engelstein, PhD
Expedited partner therapy is an ethical and effective treatment for sexually transmitted infection, provided patients are reliable messengers to partners.
AMA J Ethics. 2016;18(3):215-228. doi:
10.1001/journalofethics.2016.18.3.ecas3-1603.
Vegan patients screened for vitamin and mineral deficiencies might benefit from supplements, but physicians are obliged to discuss lack of regulation in the supplement industry and possible risks.
AMA J Ethics. 2018;20(11):E1025-1032. doi:
10.1001/amajethics.2018.1025.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.